Cytokines and Growth Factors Expressed by Human Cutaneous Melanoma

IL-8 single-chain homodimers and heterodimers: Interactions with the chemokine receptors CXCR1, CXCR2, and DARC

(2010) Steven R. Leong et al.   PROTEIN SCIENCE

Ex vivo expansion of tumor specific lymphocytes with IL-15 and IL-21 for adoptive immunotherapy in melanoma

(2009) Eduardo Huarte et al.   CANCER LETTERS

Small-Molecule Antagonists for CXCR2 and CXCR1 Inhibit Human Melanoma Growth by Decreasing Tumor Cell Proliferation, Survival, and Angiogenesis

(2009) S. Singh et al.   CLINICAL CANCER RESEARCH

Erlotinib and Bevacizumab Have Synergistic Activity against Melanoma

(2009) N. Schicher et al.   CLINICAL CANCER RESEARCH

Functional activity of CXCL8 receptors, CXCR1 and CXCR2, on human malignant melanoma progression

(2009) Chiara Gabellini et al.   EUROPEAN JOURNAL OF CANCER

Protumor vs Antitumor Functions of IL-17

(2009) G. Murugaiyan et al.   JOURNAL OF IMMUNOLOGY

CTLA4 blockade increases Th17 cells in patients with metastatic melanoma

(2009) Erika von Euw et al.   Journal of Translational Medicine

TNF-Based Isolated Limb Perfusion Followed by Consolidation Biotherapy with Systemic Low-dose Interferon Alpha 2b in Patients with In-transit Melanoma Metastases: A Pilot Trial

(2008) Carlo Riccardo Rossi et al.   ANNALS OF SURGICAL ONCOLOGY

Osteopontin as a target for cancer therapy

(2008) Nicholas IF Johnston   Frontiers in Bioscience-Landmark

Reduced expression of IL-18 is a marker of ultraviolet radiation-induced melanomas

(2008) Elke Hacker et al.   INTERNATIONAL JOURNAL OF CANCER

Transforming growth factor-β in cutaneous melanoma

(2008) Delphine Javelaud et al.   Pigment Cell & Melanoma Research

IGF1 Promotes Resistance to Apoptosis in Melanoma Cells through an Increased Expression of BCL2, BCL-X(L), and Survivin

(2007) Caroline Hilmi et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY